The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> BIOLOGY >> NEWS
American Society for Microbiology selects Mass Media Fellows

icine in New York. She is currently pursuing postdoctoral studies at Harvard Medical School. She is also a member of the American Association for the Advancement of Science and the American Medical Writers Association.

The fellowship program places fellows at newspapers, magazines, radio and television stations throughout the country. They receive a weekly stipend and all travel expenses paid. In early June fellows meet in Washington, D.C. to take part in an orientation session consisting of basic journalism workshops and visits to various newsrooms.

Prospective fellows must demonstrate a commitment to public understanding of science and technology and should be working on or have obtained an advanced degree in microbiology. Applications and further information can be found on ASM's website at www.asmusa.org. The American Society for Microbiology is the largest single life science society, with 43,000 members worldwide who work as scientists, teachers, physicians, and health professionals. Its mission is to promote research and research training in the microbiological sciences and to assist communication between scientists, policymakers, and the public to improve health, the environment, and economic well being.


'"/>

Contact: Barbara Hyde
bhyde@asmusa.org
202-942-9206
American Society for Microbiology
18-Apr-2001


Page: 1 2

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: American Society for Microbiology selects Mass Media Fellows

(Date:11/23/2009)...160 participants gathered this week for the sevent...E conference. This year,s topic, "Synthetic Biolog...dical researchers to explore the engineering, scie... field of synthetic biology. , Bonnie L. Bassler...ersity and this year,s conference chair, challenge...
(Date:11/23/2009)...e vaccine available for the H1N1 virus has been se...us. The vaccination marks the first time vaccine h...ndemic flu., Iowa State University,s Hank Harris...ne this summer and has been shipping preventive do...s for several weeks., The latest vaccines were s...
(Date:11/23/2009)...study by University of Alabama at Birmingham (UAB)...co-existing medical conditions (co-morbidity) do n...frican-Americans compared to Caucasians who also h...v. 23 in Cancer , a journal of the American Cance... BMI and co-morbidity are independent predictors o...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 1Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 2Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 3Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 4Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 1Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 2Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 3Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 4China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 1China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 2China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 3China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 4China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 5China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 6China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 7China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 8China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 9China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 10China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 11China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 12China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 13
(Date:11/24/2009)...24/PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:...advancedlasersystemsandinstrumentsforthestemcellre...tionalandfinancialresultsforthethirdquarterendedSe...1.46millioncomparedwith$1.43millioninQ32008,-Gross...nQ3,2008,-Netlossreducedto$148,000comparedto$283,0...
(Date:11/24/2009)...--HealthRoboticstodayannounced,thatithasformedanew....ThisrecentlyformedToronto-basedcompanywilloperate...t,install,andsupport,HealthRobotics,i.v.RoomoftheF...offeringsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM).,...nan"asneeded,basis"toitsstrategicpartnershipswithM...
(Date:11/23/2009)...vocative new study, a University of Utah scientist...major cause of global warming cannot be stabilize...builds the equivalent of one new nuclear power pla...ll be any substantial near-term departure from rec...sion rates," says the new paper by Tim Garrett, an...
(Date:11/23/2009)...ire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDL...7,2009astheex-dividenddateforits$200millionspecial...ontransactioncompletedonNovember2,2009.Thedividend...rdontherecorddate,December1,2009.NASDAQhassettheap...eofcommonstockforpurposesoftheex-dividenddateonNov...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
Other News:
...ole in the molecular machinery for making HIV-1 (t...scientists from the National Institute of Standard... working at the Center for Advanced Research in Bi...the mechanism, described in the Jan. 20 online edi...
...the Stanford Synchrotron Radiation Laboratory (SSR...acility, SPEAR3, guarantees a world-class program ...retary of Energy Spencer Abraham. "This is the fir...Institutes of Health have joined in funding an acc...
..., Low Cholesterol Diets......It is well known that...reased risk for coronary heart disease a major ca...erapeutic approach is to follow a diet low in satu...fect of this therapeutic diet on cholesterol respo...
...launched a new initiative to speed research on ner... that attacks the brain and spinal cord. The Socie...mpete for grants of up to $5.5 million each to pav...ction strategies in people with MS. ......"The pac...
Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory 2Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory 3Highlights of Tufts University nutrition research: January 2004 2Highlights of Tufts University nutrition research: January 2004 3Highlights of Tufts University nutrition research: January 2004 4
..., 2005 -- Results from a Phase 2 rheumatoid arthri...f golimumab (CNTO 148), a fully-human anti-TNF-alp...dpoint of the study. In this dose-ranging trial, ...o severely active RA treated with golimumab and me...
...s with the University of Florida and the Californi...ain of genetically modified mice that allow scient...erapies for Alzheimer's disease.......The developm...cess medical journal PloS Medicine, has helped sci...
It sounds like science fiction: simply swallowing a pill, or eating a specific food supplement, could permanently change your behaviour for the better, or reverse diseases such as schizophrenia, Hunti
...ardiology researchers at Cedars-Sinai Medical Cent...s virus engineered to carry a beneficial, mutant g...y of the gene's protein product that protects agai...the amount of plaque was significantly reduced, as...
Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 2Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 3Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 4Scientists engineer mice to mimic Alzheimer's therapy 2The food you eat could change your genes 2The food you eat could change your genes 3Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque 2Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque 3